Search
for

    Sort by

    Community Join

    210-240 / 1000+ results

      community Ru58841 and tretinoin for better...

      in Product  4 upvotes 2 years ago
      RU58841 and tretinoin are discussed for better absorption in hair loss treatment. The effectiveness of tretinoin with minoxidil is debated.

      community Kintor’s GT20029 Phase 1 success

      in Update  74 upvotes 3 years ago
      Kintor's GT20029, a treatment for hair loss, has completed Phase 1 successfully, showing promise as an androgen receptor degrader that could potentially regrow hair. It is considered more effective than Pyrilutamide, with infrequent dosing and minimal systemic absorption.

      community Shiseido RCH-01

       5 upvotes 7 years ago
      Shiseido RCH-01 and Replicel's upcoming trial data release. Users discuss expected release timelines and clarify quarter dates.

      community Setipiprant/PGE2 feedbacks?

      in Question  4 upvotes 8 years ago
      The conversation discusses using PGE2 as a hair growth stimulant, comparing it to minoxidil, and considering the addition of Setipiprant. Concerns about side effects like skin damage and cost are also mentioned.

      community Clascoterone - clearnet vendor

      in Chat  2 upvotes 5 months ago
      The conversation is about finding a clearnet vendor for clascoterone, also known as Winlevi, for hair loss treatment. The user is seeking recommendations via direct message.

      community Still hope on Kintor due to the new announcement

      in Treatment  19 upvotes 2 years ago
      The conversation is about Kintor's announcement indicating continued hope for their product KX-826 as a treatment for Alopecia Androgenetica. Specific treatments mentioned are Minoxidil, Finasteride, and RU58841.

      community The New, Improved CB-03-01/Setipiprant Group Buy

       27 upvotes 9 years ago
      The group buy for CB-03-01, a topical anti-androgen for hair loss, was postponed and refunded due to issues with the product's form and solubility. The product, also known as Breezula, is an alternative to finasteride with fewer side effects, but its official release is delayed until 2021.

      community Kintor money grab, unacceptable

      in Product  76 upvotes 1 year ago
      Kintor's KX826 (pyrilutamide) is ineffective at 0.5% and overpriced at 1%, leading to user frustration and calls for fair pricing. Users suggest sticking with proven treatments like Minoxidil and Finasteride.

      community [24M] 4 month update oral min/fin

      in Progress Pictures  87 upvotes 1 year ago
      The user reported good progress in hair regrowth, especially on the crown, after using oral minoxidil and finasteride for four months and recently switched to dutasteride. The community responded positively, noting realistic progress and offering tips for consistent photo documentation.

      community 4 months M26 Fin/Min/Keto/microneedle

      in Progress Pictures  39 upvotes 2 years ago
      A 26-year-old male shared progress pictures after 4 months of treating hair loss with finasteride (1.25 mg on Mondays, Wednesdays, and Fridays), topical minoxidil twice daily, ketoconazole shampoo twice weekly, and weekly microneedling at 1.5 mm. He is seeing hair growth improvement, especially in the front, and is considering hair grafts for the crown area if necessary for more density.

      community 4 month progress. Oral fin and topical min

      in Progress Pictures  1443 upvotes 1 year ago
      A user shared their 4-month hair regrowth progress using oral finasteride and topical minoxidil, reporting no side effects and positive feedback on their appearance. The post sparked debate, with many users doubting the authenticity of the photos, while others congratulated the user on their impressive results.

      community It looks like Pelage are giving hints that PP405 is a game changer

      in Chat  239 upvotes 2 months ago
      PP405 is seen as a potential breakthrough for converting vellus hairs to terminal hairs, with users expressing both hope and skepticism. It is compared to treatments like minoxidil and finasteride, with discussions on side effects and marketing concerns.

      community where and how to do Verteporfin after HT

      in Transplants  4 upvotes 2 years ago
      The conversation is about a user planning to undergo a hair transplant and seeking information on clinics that perform Verteporfin treatment. A user suggests Dr. Barghouthi might offer this service.

      community 4 Years Post-Op, How is Looking?

      in Is this regrowth?  1876 upvotes 1 year ago
      A user expressed satisfaction with a hair and beard transplant at HairofIstanbul using 3200 grafts and PRP, achieving natural-looking results without finasteride or minoxidil. The transformation was praised, though some noted the beard line appeared artificial.

      community 4 years on finasteride update!

      in Progress Pictures  256 upvotes 2 years ago
      A 25-year-old has been using finasteride for four years to treat hair loss, starting at age 21, and has experienced significant hair thickening without side effects. Others in the conversation share varied results and experiences with finasteride, with some considering adding minoxidil to their treatment.

      community 4 months after my hairtransplant

      in Progress Pictures  65 upvotes 1 year ago
      The user had a hair transplant at Vera Clinic Istanbul and is using 1mg Finasteride six times a week, 0.5mg Dutasteride once a week, and topical Minoxidil daily. They wash out the Minoxidil each morning and are happy with the results, noting the importance of medication to prevent further hair loss.

      community PP405 (Everychem 3HP) users - assemble and share your updates!!

      in Chat  44 upvotes 1 month ago
      Users discussed experiences with Everychem's solution similar to PP405 for hair loss, noting some positive results like increased hair thickness and new growth. There was skepticism about the product's legitimacy and safety, with some users reporting early signs of effectiveness and others expressing concerns about the lack of evidence and safety profiles.